The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 28, 2021
Filed:
Jan. 31, 2020
Applicant:
Arcutis, Inc., Westlake Village, CA (US);
Inventors:
David W. Osborne, Fort Collins, CO (US);
Bhaskar Chaudhuri, Westlake Village, CA (US);
Archie W. Thurston, Jr., San Diego, CA (US);
Assignee:
Arcutis Biotherapeutics, Inc., Westlake Village, CA (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/44 (2006.01); A61K 47/10 (2017.01); A61K 9/00 (2006.01); A61K 47/24 (2006.01); A61P 17/06 (2006.01); A61K 47/06 (2006.01); A61K 47/14 (2017.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/44 (2013.01); A61K 9/0014 (2013.01); A61K 45/06 (2013.01); A61K 47/06 (2013.01); A61K 47/10 (2013.01); A61K 47/14 (2013.01); A61K 47/24 (2013.01); A61P 17/06 (2018.01);
Abstract
The present invention is directed to methods for improving the therapeutic outcome of treatment with roflumilast. The therapeutic outcome is improved by consistent delivery and/or a longer plasma half-life of a topically administered roflumilast composition. The roflumilast composition preferably includes dicetyl phosphate, ceteth-10 phosphate, diethylene glycol monoethyl ether, and/or hexylene glycol.